Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Editorial: Mathematical modeling in discovery and analysis of immune responses.

Frontiers in immunology·2026

Same author

Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.

PLoS computational biology·2025

Same author

HnRNP L is essential for peripheral T cell proliferation and survival.

Frontiers in immunology·2025

Same author

FCGR2C Q<sup>13</sup> and FCGR3A V<sup>176</sup> alleles jointly associate with worse natural killer cell-mediated antibody-dependent cellular cytotoxicity and microvascular inflammation in kidney allograft antibody-mediated rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2024

Same author

Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.

bioRxiv : the preprint server for biology·2024

Same author

Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function.

ImmunoHorizons·2024

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Dendritic cell immunotherapy for autoimmune diabetes.

Maryam Feili-Hariri¹, Rafael R Flores, A Cecilia Vasquez

¹Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, USA. haririmf@upmc.edu

Immunologic Research

|March 6, 2007

Summary

Specific dendritic cell (DC) subsets can prevent type 1 diabetes in mice. These mature DCs promote regulatory T cells, highlighting the need for optimized isolation methods for therapeutic applications.

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Related Experiment Videos

Last Updated: Jun 27, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Area of Science:

Immunology
Endocrinology
Autoimmunity

Background:

Dendritic cells (DCs) are crucial for initiating immune responses and maintaining self-tolerance.
DCs play a significant role in the pathogenesis of type 1 diabetes.
Research is exploring the potential of specific DC subsets to prevent diabetes.

Purpose of the Study:

To investigate the role of dendritic cells in type 1 diabetes pathogenesis.
To identify DC subsets capable of preventing diabetes in non-obese diabetic (NOD) mice.
To review advances in isolating therapeutic DCs.

Main Methods:

Studying the role of DCs in type 1 diabetes models.
Analyzing the phenotype of diabetes-preventing DC subsets.
Investigating the induction of regulatory Th2 cells by therapeutic DCs.
Reviewing methods for optimizing DC culture and purification.

Main Results:

Specific DC subsets that prevent diabetes in NOD mice exhibit a mature phenotype.
These therapeutic DC subsets induce the production of regulatory Th2 cells.
Optimizing culture conditions and purification is crucial for isolating effective therapeutic DCs.

Conclusions:

Mature dendritic cell subsets hold therapeutic potential for preventing type 1 diabetes.
The induction of regulatory Th2 cells is a key mechanism of DC-mediated diabetes prevention.
Further optimization of DC isolation techniques is essential for clinical translation.